StratDeck

Two stocks in Drug Manufacturers - General

Johnson & Johnson vs Pfizer: profit, growth, debt and price compared

Johnson & Johnson is stronger on 4 of 7 figures: profit margin, sales growth, debt and price trend. Pfizer is stronger on 2: price for its expected profit and dividend.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore Johnson & Johnson's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Johnson & Johnson and Pfizer side by side
Johnson & JohnsonJNJPfizerPFE
Net marginStronger: 16.2%6.3%
Revenue growth, past yearStronger: +5.86%−0.43%
Debt to equityStronger: 54.8%71.0%
Forward P/E23.5×Stronger: 9.5×
Dividend yield1.94%Stronger: 6.13%
AnalystsBuy · 22Buy · 26
From its 200-day averageStronger: +10.2%+6.1%

Share price over the past year

  • Johnson & Johnson+36.3%
  • Pfizer+10.3%

18 Nov 202518 Nov 2026

Johnson & Johnson or Pfizer: which is stronger?

  • JNJ

    Which is more profitable?

    Johnson & Johnson keeps more of each sale as profit: 16.2% against 6.3%.

  • JNJ

    Which is growing its sales faster?

    Johnson & Johnson is growing its sales faster: +5.86% over the past year, against −0.43%.

  • JNJ

    Which has borrowed less?

    Johnson & Johnson has borrowed less: its debt is 54.8% of what its shareholders own, against 71.0% for Pfizer.

  • PFE

    Which costs less for the profit it is expected to make?

    Pfizer costs less for the profit it is expected to make: 9.5× its forward earnings, against 23.5×.

  • PFE

    Which pays more in dividends?

    Pfizer pays more back in dividends for what a share costs: 6.13% a year, against 1.94%.

  • Which do analysts rate higher?

    Analysts rate both the same: Buy.

  • JNJ

    Which is in the stronger price trend?

    Johnson & Johnson's price is in the stronger trend: 10.2% above its 200-day average, against 6.1% above.

What each company does

JNJJohnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

Reports results on 26 January 2027

PFEPfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Reports results on 2 February 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.